NOT-DA-17-029: Notice of Correction to RFA-DA-18-005 "Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33)"

Notice of Correction to RFA-DA-18-005 "Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33)"

Notice Number: NOT-DA-17-029

Key Dates
Release Date: April 21, 2017

Related Announcements
RFA-DA-18-005

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice of correction for the RFA-DA-18-005 "Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33)" is to correct language in the Funding Opportunity Description section.

Current Language
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
Research Goals
Projects must leverage an opportunity made available by funding that states receive under SAMHSA TI-17-04.

New Language
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
Research Goals
Projects must leverage an opportunity made available by funding that states receive under SAMHSA TI-17-014.

All other aspect of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Sarah Q. Duffy, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: Sarah.Duffy@nih.gov